1. Home
  2. HYLN vs BWAY Comparison

HYLN vs BWAY Comparison

Compare HYLN & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hyliion Holdings Corp.

HYLN

Hyliion Holdings Corp.

HOLD

Current Price

$1.98

Market Cap

348.4M

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$13.65

Market Cap

450.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HYLN
BWAY
Founded
2018
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
348.4M
450.8M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
HYLN
BWAY
Price
$1.98
$13.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$5.00
$13.25
AVG Volume (30 Days)
946.6K
130.3K
Earning Date
05-28-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,475,000.00
N/A
Revenue This Year
$32.29
$301.23
Revenue Next Year
$174.03
$24.33
P/E Ratio
N/A
$81.98
Revenue Growth
130.28
N/A
52 Week Low
$1.11
$7.84
52 Week High
$2.56
$26.63

Technical Indicators

Market Signals
Indicator
HYLN
BWAY
Relative Strength Index (RSI) 46.50 29.39
Support Level $1.86 $11.55
Resistance Level $2.04 $17.20
Average True Range (ATR) 0.13 1.05
MACD -0.00 -0.64
Stochastic Oscillator 37.50 14.18

Price Performance

Historical Comparison
HYLN
BWAY

About HYLN Hyliion Holdings Corp.

Hyliion Holdings Corp provides solutions that enable clean, flexible, and affordable electricity production. The Company focuses on delivering distributed power generators that can operate on various fuel sources to future-proof against an ever-changing energy economy. It is initially targeting the commercial and waste management industries with a locally deployable generator that can offer prime power as well as energy arbitrage opportunities. In addition to stationary power solutions, it focuses on mobile applications, including vehicles and marine technologies.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: